Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
Picket, AndyToxin Science Limited, Wrexham, UK; Botulinum research Center, UMASS Dartmouth, MA, USAModern clinical use of botulinum toxin (BoNT) by doctors requires evidence- based facts and data to support their work. In particular, these need to be unbiased and complete. Too often in the past, spe...
Guardado en:
Autor principal: | Pickett A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f46c94a934842248ae15ea23865ba92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Botulinum toxin injections for blepharospasm prior to ocular surgeries
por: Kaydu E, et al.
Publicado: (2012) -
Unilateral transient mydriasis and ptosis after botulinum toxin injection for a cosmetic procedure
por: Akkaya S, et al.
Publicado: (2015) -
Long-Term Effects of Botulinum Toxin in Large-Angle Infantile Esotropia
por: Gallo FG, et al.
Publicado: (2020) -
The Efficacy of Dose Increments of Botulinum Toxin A in the Treatment of Childhood Esotropia
por: Alshamlan FT, et al.
Publicado: (2021) -
Reviews of botulinum toxin products in aesthetic use must be accurate, clear and avoid speculation
por: Pickett A
Publicado: (2013)